Decreased Tongue Strength is Related to Skeletal Muscle Mass in COPD Subjects

Sponsor
Kindai University (Other)
Overall Status
Completed
CT.gov ID
NCT04761380
Collaborator
(none)
51
1
5.3
9.6

Study Details

Study Description

Brief Summary

Background:

Dysphagia is frequently observed in subjects with chronic obstructive pulmonary disease (COPD). But tongue strength has not been investigated yet in COPD subjects. The investigators hypothesized that tongue strength is weaker in COPD subjects compared to normal subjects.

Methods:

This was a single-centre, observational, and cross-sectional study. Twenty-seven subjects with COPD and twenty-four age-matched control subjects were enrolled in this study. Isometric tongue strength was measured using a device fitted with a disposable oral balloon probe. The investigators also evaluated handgrip strength, gait speed, and appendicular skeletal muscle mass (ASM) to define participants as having sarcopenia. ASM, fat free mass index (FFMI), and skeletal muscle mass index (SMI) were measured by bioelectrical impedance analysis. Gait speed was measured using the 6-meter walking test. The eating assessment test-10 (EAT-10) was used to diagnose dysphagia.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: balloon-based tongue pressure measurement device

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
51 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Decreased Tongue Strength is Related to Skeletal Muscle Mass in COPD Subjects
Actual Study Start Date :
Dec 1, 2019
Actual Primary Completion Date :
May 10, 2020
Actual Study Completion Date :
May 10, 2020

Arms and Interventions

Arm Intervention/Treatment
stable COPD subjects

Diagnostic Test: balloon-based tongue pressure measurement device
The probe was inflated at a baseline pressure of 19.6 kilopascal (kPa). To measure MTP, the balloon was positioned on the anterior palate with the lips closed. Subjects raised their tongue and compressed the balloon onto the palate with maximal voluntary muscular effort for approximately 7s. The measurement was taken three times with a 1-min interval. The maximum value was recorded as the MTP.
Other Names:
  • Bioelectrical impedance analysis
  • age-matched control subjects subjects who did not have any pulmonary disease

    Diagnostic Test: balloon-based tongue pressure measurement device
    The probe was inflated at a baseline pressure of 19.6 kilopascal (kPa). To measure MTP, the balloon was positioned on the anterior palate with the lips closed. Subjects raised their tongue and compressed the balloon onto the palate with maximal voluntary muscular effort for approximately 7s. The measurement was taken three times with a 1-min interval. The maximum value was recorded as the MTP.
    Other Names:
  • Bioelectrical impedance analysis
  • Outcome Measures

    Primary Outcome Measures

    1. maximum tongue pressure [1 day]

      To measure maximum tongue pressure (MTP), the balloon was positioned on the anterior palate with the lips closed. Subjects raised their tongue and compressed the balloon onto the palate with maximal voluntary muscular effort for approximately 7s. The measurement was taken three times with a 1-min interval. The maximum value was recorded as the MTP.

    Secondary Outcome Measures

    1. handgrip strength [1 day]

      Handgrip strength was measured three times for the right hand using a grip strength dynamometer and mean values were used.

    2. fat free mass index (FFMI) [1 day]

      FFMI (kg/m^2) was calculated by fat free mass/height^2(m^2).

    3. skeletal muscle mass (SMI) [1 day]

      SMI (kg/m^2) was calculated by skeletal muscle mass /height^2(m^2).

    4. fat free mass [1 day]

      Fat free mass was measured using the medical body composition analyzer. It is designed for measurements in the supine position, using four pairs of electrodes (eight electrodes in total), positioned on each hand and foot21. Supine measurements were taken after lying down for 10 minutes. Alcohol was prohibited for 24h prior to the impedance measurements.

    5. skeletal muscle mass [1 day]

      Skeletal muscle mass was measured using the medical body composition analyzer. It is designed for measurements in the supine position, using four pairs of electrodes (eight electrodes in total), positioned on each hand and foot21. Supine measurements were taken after lying down for 10 minutes. Alcohol was prohibited for 24h prior to the impedance measurements.

    6. height [1 day]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Clinical diagnosis of stable COPD.

    • Age-matched control subjects who did not have any pulmonary disease.

    Exclusion Criteria:
    • Participants with metallic implants.

    • History of stroke disease.

    • History of neuromuscular disease.

    • Participants who did not have their front teeth.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Kindai University Faculty of Medicine Ōsaka-sayama Osaka Japan 5898511

    Sponsors and Collaborators

    • Kindai University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Kindai University
    ClinicalTrials.gov Identifier:
    NCT04761380
    Other Study ID Numbers:
    • 0414
    First Posted:
    Feb 18, 2021
    Last Update Posted:
    Feb 18, 2021
    Last Verified:
    Feb 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Kindai University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 18, 2021